Uncontrolled Bleeding in Surgical Patients: The Role of Recombinant Activated Factor VIIa

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|10|8|744-770

ISSN： 1389-4501

Source： Current Drug Targets, Vol.10, Iss.8, 2009-08, pp. : 744-770

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recombinant Factor VIIa (Eptacog Alfa): A Review of its Use in Congenital or Acquired Haemophilia and Other Congenital Bleeding Disorders

By Siddiqui M. Asif A.   Scott Lesley J.  

Drugs, Vol. 65, Iss. 8, 2005-01 ,pp. : 1161-1177

Adis International

Access to resources Recommend Favorite

Management of bleeding emergencies: when to use recombinant activated Factor VII

By DeLoughery Thomas G  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 1, 2006-01 ,pp. : 25-34

Informa Healthcare

Access to resources Recommend Favorite

Recombinant Factor VIIa (Eptacog Alfa): A Pharmacoeconomic Review of its Use in Haemophilia in Patients with Inhibitors to Clotting Factors VIII or IX

By Lyseng-Williamson Katherine A.   Plosker Greg L.  

PharmacoEconomics, Vol. 25, Iss. 12, 2007-01 ,pp. : 1007-1029

Adis International

Access to resources Recommend Favorite

Eptacog alfa [recombinant factor VIIa] reduces perioperative blood loss in patients undergoing retropubic prostatectomy

By  

Inpharma, Vol. 1, Iss. 1371, 2003-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Recombinant activated Factor VII in major surgery and trauma patients: a response

By Zakhary Randa Grob   Seremetis Stephanie  

Expert Opinion on Drug Safety, Vol. 4, Iss. 5, 2005-09 ,pp. : 813-814

Informa Healthcare

Access to resources Recommend Favorite